Drug intelligence / Profile preview

Qibang Tangshen Formula

Development stage
Unknown
Lead developer
Longhua Hospital Shanghai University of Traditional Chinese Medicine
Modality
Small Molecules
Administration
Oral
01

Overview

Qibang Tangshen Formula (QBTF) is a Traditional Chinese Medicine (TCM) herbal compound developed by the Longhua Hospital affiliated with the Shanghai University of Traditional Chinese Medicine. It is specifically formulated for the treatment of diabetic kidney disease (DKD) and type 2 diabetes mellitus. The formula typically consists of several botanical ingredients, including *Astragalus membranaceus* and *Rehmannia glutinosa*, which are selected to address the TCM patterns of Qi-Yin deficiency and blood stasis. QBTF exerts its therapeutic effects by reducing proteinuria, improving glomerular filtration rates, and protecting podocytes from injury. Its molecular mechanism involves the inhibition of renal fibrosis and inflammation, primarily through the downregulation of the TGF-β1/Smad signaling pathway and the suppression of pro-inflammatory cytokines like NF-κB.

Other names
Qibang Tangshen decoctionQibang Tangshen granules
02

Targets

NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)

Beyond the preview

Go deeper on Qibang Tangshen Formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qibang Tangshen Formula.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call